Trump Claims on Drug Prices Range From 'Fake' to 'Exaggerated' to 'Probably Won't Happen': Analysis

A new analysis published Thursday argues that President Donald Trump's claims about prescription drug price reductions under his administration fall into one of three categories: "fake," "exaggerated," or "probably won't happen." The analysis , released by the consumer advocacy group Public Citizen, came after Trump recently—and buffoonishly —tried to take credit for what was described as the…